P. Ntziachristos, J. Mullenders, T. Trimarchi, and I. Aifantis, Mechanisms of Epigenetic Regulation of Leukemia Onset and Progression, Adv Immunol, vol.117, pp.1-38, 2013.
DOI : 10.1016/B978-0-12-410524-9.00001-3

F. Ferrara and C. Schiffer, Acute myeloid leukaemia in adults, The Lancet, vol.381, issue.9865, pp.484-495, 2013.
DOI : 10.1016/S0140-6736(12)61727-9

H. De-jonge, G. Huls, and E. De-bont, Gene expression profiling in acute myeloid leukaemia, The Netherlands Journal of Medicine, vol.69, pp.167-176, 2011.

G. Roboz, Current treatment of acute myeloid leukemia, Current Opinion in Oncology, vol.24, issue.6, pp.711-719, 2012.
DOI : 10.1097/CCO.0b013e328358f62d

D. Breems, W. Van-putten, and P. Huijgens, Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse, Journal of Clinical Oncology, vol.23, issue.9, pp.1969-1978, 2005.
DOI : 10.1200/JCO.2005.06.027

J. Patel, M. Gönen, and M. Figueroa, Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia, New England Journal of Medicine, vol.366, issue.12, pp.1079-1089, 2012.
DOI : 10.1056/NEJMoa1112304

F. Appelbaum, H. Gundacker, and D. Head, Age and acute myeloid leukemia, Blood, vol.107, issue.9, pp.3481-3485, 2006.
DOI : 10.1182/blood-2005-09-3724

C. Pui and W. Evans, Treatment of Acute Lymphoblastic Leukemia, New England Journal of Medicine, vol.354, issue.2, pp.166-178, 2006.
DOI : 10.1056/NEJMra052603

B. Druker, Translation of the Philadelphia chromosome into therapy for CML, Blood, vol.112, issue.13, pp.4808-4817, 2008.
DOI : 10.1182/blood-2008-07-077958

B. Druker, F. Guilhot, O. Brien, and S. , Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia, New England Journal of Medicine, vol.355, issue.23, pp.2408-2417, 2006.
DOI : 10.1056/NEJMoa062867

M. Holtz, S. Forman, and R. Bhatia, Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli, Leukemia, vol.98, issue.6, pp.1034-1041, 2005.
DOI : 10.1038/sj.leu.2403724

P. Cramer and M. Hallek, Hematological cancer in 2011: New therapeutic targets and treatment strategies, Nature Reviews Clinical Oncology, vol.29, issue.2, pp.72-74, 2012.
DOI : 10.1038/nrclinonc.2011.212

D. Catovsky, S. Richards, and E. Matutes, Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial, The Lancet, vol.370, issue.9583, pp.230-239, 2007.
DOI : 10.1016/S0140-6736(07)61125-8

M. Keating, O. Brien, S. Albitar, and M. , Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia, Journal of Clinical Oncology, vol.23, issue.18, pp.4079-4088, 2005.
DOI : 10.1200/JCO.2005.12.051

R. Bamford, A. Grant, and J. Burton, The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells., Proceedings of the National Academy of Sciences, vol.91, issue.11, pp.4940-4944, 1994.
DOI : 10.1073/pnas.91.11.4940

K. Grabstein, J. Eisenman, and K. Shanebeck, Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor, Science, vol.264, issue.5161, pp.965-968, 1994.
DOI : 10.1126/science.8178155

T. Fehniger and M. Caligiuri, Interleukin 15: biology and relevance to human disease, Blood, vol.97, issue.1, pp.14-32, 2001.
DOI : 10.1182/blood.V97.1.14

J. Steel, T. Waldmann, and J. Morris, Interleukin-15 biology and its therapeutic implications in cancer, Trends in Pharmacological Sciences, vol.33, issue.1, pp.35-41, 2012.
DOI : 10.1016/j.tips.2011.09.004

Y. Tagaya, G. Kurys, and T. Thies, Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides, Proceedings of the National Academy of Sciences, vol.94, issue.26, pp.14444-14449, 1997.
DOI : 10.1073/pnas.94.26.14444

S. Bulfone-paus, E. Bulanova, V. Budagian, and R. Paus, The interleukin-15/interleukin-15 receptor system as a model for juxtacrine and reverse signaling, BioEssays, vol.6, issue.4, pp.362-377, 2006.
DOI : 10.1002/bies.20380

M. Jakobisiak, J. Golab, and W. Lasek, Interleukin 15 as a promising candidate for tumor immunotherapy, Cytokine & Growth Factor Reviews, vol.22, issue.2, pp.99-108, 2011.
DOI : 10.1016/j.cytogfr.2011.04.001

S. Olsen, N. Ota, and S. Kishishita, Crystal Structure of the Interleukin-15{middle dot}Interleukin-15 Receptor ?? Complex: INSIGHTS INTO TRANS AND CIS PRESENTATION, Journal of Biological Chemistry, vol.282, issue.51, pp.37191-37204, 2007.
DOI : 10.1074/jbc.M706150200

J. Johnston, C. Bacon, and D. Finbloom, Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15., Proceedings of the National Academy of Sciences, vol.92, issue.19, pp.8705-8709, 1995.
DOI : 10.1073/pnas.92.19.8705

H. Gu, H. Maeda, and J. Moon, New Role for Shc in Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway, Molecular and Cellular Biology, vol.20, issue.19, pp.7109-7120, 2000.
DOI : 10.1128/MCB.20.19.7109-7120.2000

S. Adunyah, B. Wheeler, and R. Cooper, Evidence for the Involvement of LCK and MAP Kinase (ERK-1) in the Signal Transduction Mechanism of Interleukin-15, Biochemical and Biophysical Research Communications, vol.232, issue.3, pp.754-758, 1997.
DOI : 10.1006/bbrc.1997.6367

T. Miyazaki, Z. Liu, and A. Kawahara, Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation, Cell, vol.81, issue.2, pp.223-231, 1995.
DOI : 10.1016/0092-8674(95)90332-1

T. Waldmann, The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design, Nature Reviews Immunology, vol.153, issue.8, pp.595-601, 2006.
DOI : 10.1038/nri1901

M. Imamura, D. Shook, and T. Kamiya, Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15, Blood, vol.124, issue.7, pp.1081-1088, 2014.
DOI : 10.1182/blood-2014-02-556837

T. Stoklasek, K. Schluns, and L. Lefrançois, Combined IL-15/IL-15R?? Immunotherapy Maximizes IL-15 Activity In Vivo, The Journal of Immunology, vol.177, issue.9, pp.6072-6080, 2006.
DOI : 10.4049/jimmunol.177.9.6072

B. Ahmed, M. , B. Hmida, N. Moes, and N. , IL-15 Renders Conventional Lymphocytes Resistant to Suppressive Functions of Regulatory T Cells through Activation of the Phosphatidylinositol 3-Kinase Pathway, The Journal of Immunology, vol.182, issue.11
DOI : 10.4049/jimmunol.0801792

URL : https://hal.archives-ouvertes.fr/pasteur-01375190

M. Gil, S. Park, Y. Chung, and C. Park, Interleukin-15 enhances proliferation and chemokine secretion of human follicular dendritic cells, Immunology, vol.8, issue.4, pp.536-544, 2010.
DOI : 10.1111/j.1365-2567.2010.03252.x

F. Mattei, G. Schiavoni, F. Belardelli, and D. Tough, IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation, The Journal of Immunology, vol.167, issue.3, pp.1179-1187, 2001.
DOI : 10.4049/jimmunol.167.3.1179

B. Pulendran, S. Dillon, C. Joseph, T. Curiel, J. Banchereau et al., Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responsesin vivo, European Journal of Immunology, vol.34, issue.1, pp.66-73, 2004.
DOI : 10.1002/eji.200324567

T. Waldmann, Contrasting Roles of IL-2 and IL-15 in the Life and Death of Lymphocytes, Immunity, vol.14, issue.2, pp.161-167, 2002.
DOI : 10.1016/S1074-7613(01)00093-0

D. Hodge, J. Yang, and M. Buschman, Interleukin-15 Enhances Proteasomal Degradation of Bid in Normal Lymphocytes: Implications for Large Granular Lymphocyte Leukemias, Cancer Research, vol.69, issue.9, pp.3986-3994, 2009.
DOI : 10.1158/0008-5472.CAN-08-3735

N. Azimi, S. Jacobson, T. Leist, and T. Waldmann, Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor, J Immunol, vol.163, issue.7, pp.4064-4072, 1999.

J. Mariner, V. Lantz, T. Waldmann, and N. Azimi, Human T Cell Lymphotropic Virus Type I Tax Activates IL-15R?? Gene Expression Through an NF-??B Site, The Journal of Immunology, vol.166, issue.4, pp.2602-2609, 2001.
DOI : 10.4049/jimmunol.166.4.2602

S. Takemoto, J. Mulloy, and A. Cereseto, Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins, Proceedings of the National Academy of Sciences, vol.94, issue.25, pp.13897-13902, 1997.
DOI : 10.1073/pnas.94.25.13897

H. Chung, H. Young, and P. Goon, Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines, Blood, vol.102, issue.12, pp.4130-4136, 2003.
DOI : 10.1182/blood-2003-04-1043

T. Lamy and T. Loughran, Current concepts: large granular lymphocyte leukemia, Blood Reviews, vol.13, issue.4, pp.230-240, 1999.
DOI : 10.1054/blre.1999.0118

R. Zambello, M. Facco, and L. Trentin, Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes, Blood, vol.89, issue.1, pp.201-211, 1997.

J. Chen, M. Petrus, and R. Bamford, Increased serum soluble IL-15R?? levels in T-cell large granular lymphocyte leukemia, Blood, vol.119, issue.1, pp.137-143, 2012.
DOI : 10.1182/blood-2011-04-346759

A. Mishra, L. Sullivan, and M. Caligiuri, Molecular Pathways: Interleukin-15 Signaling in Health and in Cancer, Clinical Cancer Research, vol.20, issue.8, pp.2044-2050, 2014.
DOI : 10.1158/1078-0432.CCR-12-3603

H. Koskela, S. Eldfors, and P. Ellonen, Mutations in Large Granular Lymphocytic Leukemia, New England Journal of Medicine, vol.366, issue.20, pp.1905-1913, 2012.
DOI : 10.1056/NEJMoa1114885

A. Jerez, M. Clemente, and H. Makishima, STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia, Blood, vol.120, issue.15, pp.3048-3057, 2012.
DOI : 10.1182/blood-2012-06-435297

A. Mishra, S. Liu, and G. Sams, Aberrant Overexpression of IL-15 Initiates Large Granular Lymphocyte Leukemia through Chromosomal Instability and DNA Hypermethylation, Cancer Cell, vol.22, issue.5, pp.645-655, 2012.
DOI : 10.1016/j.ccr.2012.09.009

J. Yu, T. Mitsui, and M. Wei, NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human, Journal of Clinical Investigation, vol.121, issue.4, pp.1456-1470, 2011.
DOI : 10.1172/JCI43242DS1

E. Mrózek, P. Anderson, and M. Caligiuri, Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells, Blood, vol.87, issue.7, pp.2632-2640, 1996.

L. Trentin, A. Cerruti, and R. Zambello, Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders, Blood, vol.87, issue.8, pp.3327-3336, 1996.

R. Zambello, M. Facco, and L. Trentin, Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes, Blood, vol.89, issue.1, pp.201-211, 1997.

A. Rosolen, M. Nakanishi, and D. Poplack, Expression of interleukin-2 receptor beta subunit in hematopoietic malignancies, Blood, vol.73, issue.7, pp.1968-1972, 1989.

H. Drexler, M. Zaborski, and H. Quentmeier, Cytokine response profiles of human myeloid factor-dependent leukemia cell lines, Leukemia, vol.11, issue.5, pp.701-708, 1997.
DOI : 10.1038/sj.leu.2400633

R. Meazza, S. Basso, and A. Gaggero, Interleukin (IL)-15 induces survival and proliferation of the growth factor-dependent acute myeloid leukemia M-07e through the IL-2 receptor ??/??, International Journal of Cancer, vol.89, issue.2, pp.189-195, 1998.
DOI : 10.1002/(SICI)1097-0215(19981005)78:2<189::AID-IJC12>3.0.CO;2-6

G. Cario, S. Izraeli, and A. Teichert, High Interleukin-15 Expression Characterizes Childhood Acute Lymphoblastic Leukemia With Involvement of the CNS, Journal of Clinical Oncology, vol.25, issue.30, pp.4813-4820, 2007.
DOI : 10.1200/JCO.2007.11.8166

M. Williams, Y. Yousafzai, and C. Cox, Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia, Blood, vol.123, issue.20, pp.3116-3127, 2014.
DOI : 10.1182/blood-2013-05-499970

D. Petranovic, G. Pilcic, T. Valkovic, S. Tokmadzic, V. Laskarin et al., Perforin- and granulysin-mediated cytotoxicity and interleukin 15 play roles in neurocognitive impairment in patients with acute lymphoblastic leukaemia, Medical Hypotheses, vol.83, issue.1, pp.122-126, 2014.
DOI : 10.1016/j.mehy.2014.03.024

X. Zhang, K. Yan, and Z. Wang, Polymorphisms in Interleukin-15 Gene on Chromosome 4q31.2 Are Associated with Psoriasis Vulgaris in Chinese Population, Journal of Investigative Dermatology, vol.127, issue.11, pp.2544-2551, 2007.
DOI : 10.1038/sj.jid.5700896

J. Yang, C. Cheng, and W. Yang, Genome-wide Interrogation of Germline Genetic Variation Associated With Treatment Response in Childhood Acute Lymphoblastic Leukemia, JAMA, vol.301, issue.4, pp.393-403, 2009.
DOI : 10.1001/jama.2009.7

D. Lin, C. Liu, and M. Xue, The Role of Interleukin-15 Polymorphisms in Adult Acute Lymphoblastic Leukemia, PLoS ONE, vol.5, issue.10, p.13626, 2010.
DOI : 10.1371/journal.pone.0013626.s002

R. Aly, M. Taalab, and H. Ghazy, Influence of interleukin-15 polymorphism on the survival of adult patients with acute lymphoblastic leukaemia in Egypt, Leuk Lymphoma, 2014.

A. Carella, E. Lerma, and M. Corsetti, Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia, Blood, vol.93, issue.5, pp.1534-1539, 1999.

G. Carayol, J. Giron-michel, and B. Azzarone, Altered natural killer cell differentiation in CD34+ progenitors from Chronic Myeloid Leukemia patients, Oncogene, vol.19, issue.23, pp.2758-2766, 2000.
DOI : 10.1038/sj.onc.1203584

J. Reuther, G. Reuther, D. Cortez, A. Pendergast, and A. Baldwin, A requirement for NF-kappa B activation in Bcr-Abl-mediated??transformation, Genes & Development, vol.12, issue.7, pp.968-981, 1998.
DOI : 10.1101/gad.12.7.968

J. Washizu, H. Nishimura, N. Nakamura, Y. Nimura, and Y. Yoshikai, The NF-??B binding site is essential for transcriptional activation of the IL-15 gene, Immunogenetics, vol.48, issue.1, pp.1-7, 1998.
DOI : 10.1007/s002510050393

P. Ghia, P. Circosta, and C. Scielzo, Differential Effects on CLL Cell Survival Exerted by Different Microenvironmental Elements, Curr Top Microbiol Immunol, vol.294, pp.135-145, 2005.
DOI : 10.1007/3-540-29933-5_8

M. Nishio, T. Endo, and N. Tsukada, Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1??, Blood, vol.106, issue.3, pp.1012-1020, 2005.
DOI : 10.1182/blood-2004-03-0889

J. Burger, N. Tsukada, M. Burger, N. Zvaifler, M. Dell-'aquila et al., Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1, Blood, vol.96, issue.8, pp.2655-2663, 2000.

D. De-totero, F. Di-celle, P. Cignetti, A. Foa, and R. , The IL-2 receptor complex: expression and function on normal and leukemic B cells, Leukemia, vol.9, issue.9, pp.1425-1431, 1995.

L. Trentin, A. Cerutti, and R. Zambello, Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders, Blood, vol.87, issue.8, pp.3327-3335, 1996.

N. Bernasconi, E. Traggiai, and A. Lanzavecchia, Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells, Science, vol.298, issue.5601, pp.2199-2202, 2002.
DOI : 10.1126/science.1076071

C. Park, S. Yoon, R. Armitage, and Y. Choi, Follicular Dendritic Cells Produce IL-15 That Enhances Germinal Center B Cell Proliferation in Membrane-Bound Form, The Journal of Immunology, vol.173, issue.11, pp.6676-6683, 2004.
DOI : 10.4049/jimmunol.173.11.6676

D. De-totero, R. Meazza, and M. Capaia, The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways, Blood, vol.111, issue.2, pp.517-524, 2008.
DOI : 10.1182/blood-2007-04-087882

G. Epron, P. Ame-thomas, L. Priol, and J. , Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling, Leukemia, vol.91, issue.1, pp.139-148, 2012.
DOI : 10.1016/j.cell.2010.07.044

URL : https://hal.archives-ouvertes.fr/inserm-00869028

J. Caceres-cortes, A Potent Anti-Carcinoma and Anti-Acute Myeloblastic Leukemia Agent, AG490, Anti-Cancer Agents in Medicinal Chemistry, vol.8, issue.7, pp.717-722, 2008.
DOI : 10.2174/187152008785914752

T. Waldmann, K. Conlon, and D. Stewart, Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-Beta-1 mAb in patients with T-cell large granular lymphocytic leukemia, Blood, vol.121, issue.3, pp.476-484, 2013.
DOI : 10.1182/blood-2012-08-450585

P. Epling-burnette, J. Liu, and R. Catlett-falcone, Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression, Journal of Clinical Investigation, vol.107, issue.3, pp.351-362, 2001.
DOI : 10.1172/JCI9940

X. Wang, C. Berger, C. Wong, S. Forman, S. Riddell et al., Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice, Blood, vol.117, issue.6, pp.1888-1898, 2011.
DOI : 10.1182/blood-2010-10-310599

L. Gabriele, P. Borghi, and C. Rozera, IFN-?? promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment, Blood, vol.103, issue.3, pp.980-987, 2004.
DOI : 10.1182/blood-2003-03-0981

J. Molldrem, P. Lee, and S. Kant, Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells, Journal of Clinical Investigation, vol.111, issue.5, pp.639-647, 2003.
DOI : 10.1172/JCI200316398

J. Schwartz, J. Pinilla-ibarz, R. Yuan, and D. Scheinberg, Novel targeted and immunotherapeutic strategies in chronic myeloid leukemia, Seminars in Hematology, vol.40, issue.1, pp.87-96, 2003.
DOI : 10.1016/S0037-1963(03)70046-8

L. Maux-chansac, B. Missé, D. Richon, and C. , Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway, International Immunology, vol.20, issue.7, pp.801-810, 2008.
DOI : 10.1093/intimm/dxn038

C. Sutherland, B. Rabinovich, N. Chalupny, P. Brawand, R. Miller et al., ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15, Blood, vol.108, issue.4, pp.1313-1319, 2006.
DOI : 10.1182/blood-2005-11-011320

V. Decot, L. Voillard, and V. Latger-cannard, Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: Comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression, Experimental Hematology, vol.38, issue.5, pp.351-362, 2010.
DOI : 10.1016/j.exphem.2010.02.006

S. Yoon, Y. Lee, and S. Yang, Generation of donor natural killer cells from CD34+ progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study, Bone Marrow Transplantation, vol.90, issue.6, pp.1038-1046, 2010.
DOI : 10.1016/j.autrev.2005.04.017

E. Laprevotte, G. Voisin, and L. Ysebaert, Recombinant Human IL-15 Trans-Presentation by B Leukemic Cells from Chronic Lymphocytic Leukemia Induces Autologous NK Cell Proliferation Leading to Improved Anti-CD20 Immunotherapy, The Journal of Immunology, vol.191, issue.7, pp.3634-3640, 2013.
DOI : 10.4049/jimmunol.1300187

K. Conlon, E. Lugli, and H. Welles, Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer, Journal of Clinical Oncology, vol.33, issue.1, pp.74-82, 2015.
DOI : 10.1200/JCO.2014.57.3329

L. Blood and . Cancer, Targets and Therapy downloaded from https